Disclaimer: Retatrutide is an investigational drug that has not been approved by the U.S. Food and Drug Administration. glp3md:

• never facilitated any transactions of retatrutide;
• never promoted retatrutide for use;
• never prescribed, dispensed, or distributed retatrutide;
• never accepted payment for access to retatrutide; and
• was not affiliated with or endorsed by Eli Lilly and Company.

Waitlist signups did not reserve or guarantee access to any medication. Nothing on this website was intended as medical advice.